Vimta Labs Ltd. Stock price: Live updates

₹467.15

0.24% (1.1)

Market Cap

₹2,084 Cr.

P/E

26.89

Key Ratios

Edit Ratio's

Market cap

2,084 Cr

26.89

Prom Holding

35.85 %

ROE (%)

17.78

ROCE (%)

22.95

Div Yield (%)

0.43

Sales

407 Cr

OPM (%)

34.75 %

Debt to Equity

0.02

Institutions

5.03 %

Individual < 2 lac

23.59 %

No. of Shareholders

51,623

Edit Ratio's

About

Vimta Labs Limited, established in 1984, provides analytical, clinical, preclinical services t… Read more

Low

376

52W Range

High

903

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

13 Yes

Positive for this company

2 Neutral

Neutral for this company

2 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Vimta Labs Ltd. Business

What does Vimta Labs do?

Founded in 1984, Vimta Labs Limited provides analytical, clinical, and preclinical services to life sciences industries, quality testing for food and beverage sectors, and environmental services globally.

Who are the competitors of Vimta Labs?

Vimta Labs major competitors are Krsnaa Diagnostics, Nidan Labs. & Health, Thyrocare Tech., Metropolis Health., Vijaya Diagnostic, Dr. Lal Pathlabs, Amrutanjan Healthcar.
Market Cap of Vimta Labs is ₹2,079 Crs.
While the median market cap of its peers are ₹7,520 Crs.

Is Vimta Labs financially stable compared to its competitors?

Vimta Labs seems to be less financially stable compared to its competitors.
Altman Z score of Vimta Labs is 17.98 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Jan May	Mar Jul Nov	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Jan May	Apr Jul Nov	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Feb May	Mar Jun Nov	Mar Jun Sep	Mar Jun Sep Dec	Mar Sep Dec	Mar Sep	Mar Sep Dec	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini